Authors
Latest:
What is Needed to Turn the COVID-19 Pandemic into an EndemicFor COVID-19 to turn into an endemic, there are a few criteria that must be met.
Latest:
Clinical Overview: Oral Diabetes Medications in ChildrenDespite the surge in new diabetes cases, the treatment options in in children remain limited.
Latest:
Medically Integrated Pharmacies, Oral Oncolytic Agents Grow in Importance During COVID-19As practices have gained experience in the post-COVID-19 environment, health care professionals have found innovative ways to work around many of the obstacles the pandemic presents.
Latest:
Technology Can Help Ease Provider Burnout, Access to Health CareThe need for pharmacists to return to a more clinically-focused role became apparent as the COVID-19 pandemic revealed gaps in patient access to care across the country.
Latest:
With DSCSA Compliance Delay, Certain Requirements Still Require Action NowLaunching development of SOPs and communication with wholesalers is key.
Latest:
Managing Treatment With New and Expensive Drugs: What Pharmacy Leaders Need to KnowWith the introduction of expensive drugs and associated challenges for hospital budgets, pharmacy leaders benefit from strategically managing financial, clinical, and regulatory factors for sustainable care delivery.
Latest:
California Modifies End of Life Option ActAmendments reflecting more contemporary options could raise ethical questions for health care workers.
Latest:
Once-Weekly Insulin Analogue Demonstrates Promising Results for Those With Type 2 DiabetesPatients with type 2 diabetes receiving once-weekly insulin icodec were more likely to reach a hemoglobin A1C level below 7% compared to those who received once-daily insulin analogues.
